SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of Aetna To CVS Health Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Aetna ("Aetna" or the "Company") (NYSE: AET) stock  prior to December 3, 2017 .

You are hereby notified that Levi & Korsinsky, LLP has commenced an  investigation into the  fairness of the sale of Aetna to CVS Health (NYSE: CVS). Under the terms of the transaction, Aetna shareholders will receive $145 in cash and 0.8378 common shares of CVS Health for each Aetna share they own. The represents an approximate value of $207 per share. To learn more about the action and your rights,  go to:

or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.  There is no cost or obligation to you.

The investigation concerns whether the Board of Aetna breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether CVS Health is underpaying for Aetna shares, thus unlawfully harming Aetna shareholders.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have  recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on

Copyright Business Wire 2010